What aspects of design and implementation of LEADER deserve the greatest emphasis? What metabolic target goals and CV outcomes achieved by liraglutide were most significant?

What aspects of design and implementation of LEADER deserve the greatest emphasis? What metabolic target goals and CV outcomes achieved by liraglutide were most significant?

What aspects of the overall design and implementation of the LEADER trial do you think deserve the greatest emphasis? What metabolic target goals and CV outcomes achieved by liraglutide do you think were most significant?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Juan Frias, FACE, MD

Juan Frias, FACE, MD

Clinical Assistant Professor of Medicine
University of California
San Diego, California
Chief Medical Officer
National Research Institute
Los Angeles, California